Clinical Trials Directory

Trials / Completed

CompletedNCT02814721

Coronal Mode Ultrasound Guided Hemodialysis Cannulation: Comparison With Standard Cannulation Technique

Coronal Mode Ultrasound Guided Hemodialysis Cannulation: A Pilot Randomized Comparison With Standard Cannulation Technique

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Henry Ford Health System · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Infiltrations from cannulation difficulties result in significant morbidity including loss of vascular access (VA) loss in hemodialysis (HD). Cannulation is reliant on personnel skill and VA characteristics. Surface marking of VA lacks real-time information and traditional ultrasound (US) devices are large, expensive and require skilled operator expertise. Sonic Window© (Analogic Ultrasound, Peabody, MA) is a coronal mode ultrasound device (CMUD) approved for VA cannulation. Study is a single center randomized, prospective pilot study comparing handheld US-guided cannulation of new arteriovenous fistula (AVF) to standard cannulation practices.

Conditions

Interventions

TypeNameDescription
DEVICESonic Window ultrasound device

Timeline

Start date
2015-03-01
Primary completion
2015-08-01
Completion
2015-12-01
First posted
2016-06-28
Last updated
2024-03-01
Results posted
2024-03-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02814721. Inclusion in this directory is not an endorsement.